Skip to content

Study on the correlation between substance P and acupuncture treat delayed chemotherapy-incluced nausea and vomiting

Study on the correlation between substance P and acupuncture treat delayed chemotherapy-incluced nausea and vomiting

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17010458
Enrollment
Unknown
Registered
2017-01-17
Start date
2017-02-08
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

delayed chemotherapy-incluced nausea and vomiting

Interventions

control group:none
Acupuncture group : acupuncture treatment

Sponsors

Shanghai TCM-INTEGRATED Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. confirmed by histology or cytology; 2. Has an indication for chemotherapy and is expected to be able to complete at least 2 courses of treatment (The program contains cisplatin); 3. 24h before chemotherapy nausea and vomiting and without the use of other antiemetic drugs; 4. blood and liver function normal before chemotherapy; 5. Karnofsky score (Karnofsky) 70 points and more; 6. patients aged 18-70 years, male and female.

Exclusion criteria

Exclusion criteria: 1. does not meet the inclusion criteria. 2. drinking. 3. brain metastases. 4. history of chronic gastritis. 5. long term use of non steroidal anti-inflammatory drugs. 6. has obvious heart, liver, kidney or hematopoietic damage, or psychiatric patients, pregnant or lactating women 7. are participating in other drug experimenters. 8. can not tolerate acupuncture treatment.

Design outcomes

Primary

MeasureTime frame
Serum Substance P content;Serum Substance P content;???7?;

Countries

China

Contacts

Public ContactYang Yun

Shanghai TCM-INTEGRATED Hospital

20067225@qq.com+86 13564997811

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026